Fibulin-5 localisation in human endometrial cancer shifts from epithelial to stromal with increasing tumour grade, and silencing promotes endometrial epithelial cancer cell proliferation

Winship,Amy Louise; Rainczuk,Kate; Ton,Amanda; Dimitriadis,Eva

doi:10.3892/ol.2016.4650

Fibulin-5 localisation in human endometrial cancer shifts from epithelial to stromal with increasing tumour grade, and silencing promotes endometrial epithelial cancer cell proliferation

Authors:
- Amy Louise Winship
- Kate Rainczuk
- Amanda Ton
- Eva Dimitriadis
View Affiliations

Affiliations: Centre for Reproductive Health, The Hudson Institute of Medical Research, Melbourne, Victoria 3168, Australia
Published online on: June 1, 2016 https://doi.org/10.3892/ol.2016.4650
Pages: 651-657

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endometrial cancer is the most common invasive gynaecological malignancy. While endocrine, genetic and inflammatory factors are thought to contribute to its pathogenesis, its precise etiology and molecular regulators remain poorly understood. Fibulin‑5 is an extracellular matrix (ECM) protein that inhibits cell growth and invasion in several cancer cell types and is downregulated in a number of types of human cancer. However, it is unknown whether fibulin‑5 plays a role in endometrial tumourigenesis. In the current report, the expression and localisation of fibulin‑5 in type I endometrioid human endometrial cancers of grades (G) 1‑3 was investigated using reverse transcription‑quantitative polymerase chain reaction and immunohistochemistry. Fibulin‑5 mRNA was found to be significantly reduced in whole tumour tissues from women across G1‑3 compared with benign endometrium (P<0.0001). Consistently, fibulin‑5 protein was also reduced in the tumour epithelial compartment across increasing tumour grades. By contrast, increased protein localisation to the tumour stroma was observed with increasing grade. Knockdown by small interfering RNA in Ishikawa endometrial epithelial cancer cells expressing fibulin‑5 stimulated cell adhesion and proliferation in vitro. Fibulin‑5 mRNA expression in Ishikawa cells was induced by transforming growth factor‑β and fibulin‑5 in turn activated extracellular signal‑regulated kinases (ERK1/2), suggesting that it may act via the mitogen‑activated protein kinase pathway. In summary, the present study identified fibulin‑5 as a downregulated ECM gene in human endometrial cancer and observed a shift from epithelial to stromal protein localisation with increasing tumour grade in women. These data suggest that loss of fibulin‑5 function may promote endometrial cancer progression by enhancing epithelial cell adhesion and proliferation.

View Figures

View References

1	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
2	Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW and Lu KH: Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 105:575–580. 2005. View Article : Google Scholar : PubMed/NCBI
3	Elit L and Hirte H: Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer. Curr Opin Obstet Gynecol. 14:67–73. 2002. View Article : Google Scholar : PubMed/NCBI
4	Di Cristofano A and Ellenson LH: Endometrial Carcinoma. Annu Rev Pathol. 2:57–85. 2007. View Article : Google Scholar : PubMed/NCBI
5	Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
6	Albig AR and Schiemann WP: Fibulin-5 function during tumorigenesis. Future Oncol. 1:23–35. 2005. View Article : Google Scholar : PubMed/NCBI
7	Argraves WS, Greene LM, Cooley MA and Gallagher WM: Fibulins: Physiological and disease perspectives. EMBO Rep. 4:1127–1131. 2003. View Article : Google Scholar : PubMed/NCBI
8	Yanagisawa H, Schluterman MK and Brekken RA: Fibulin-5, an integrin-binding matricellular protein: Its function in development and disease. J Cell Commun Signal. 3:337–347. 2009. View Article : Google Scholar : PubMed/NCBI
9	Schiemann WP, Blobe GC, Kalume DE, Pandey A and Lodish HF: Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem. 277:27367–27377. 2002. View Article : Google Scholar : PubMed/NCBI
10	Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y and Liu Q: Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. BMC Cancer. 14:9382014. View Article : Google Scholar : PubMed/NCBI
11	Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, Müller M and Schulz WA: Downregulation of several fibulin genes in prostate cancer. Prostate. 67:1770–1780. 2007. View Article : Google Scholar : PubMed/NCBI
12	Hu Z, Ai Q, Xu H, Ma X, Li HZ, Shi TP, Wang C, Gong DJ and Zhang X: Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637. Urol Oncol. 29:430–435. 2011. View Article : Google Scholar : PubMed/NCBI
13	Yue W, Sun Q, Landreneau R, Wu C, Siegfried JM, Yu J and Zhang L: Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression. Cancer Res. 69:6339–6346. 2009. View Article : Google Scholar : PubMed/NCBI
14	Lee YH, Albig AR, Regner M, Schiemann BJ and Schiemann WP: Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis. 29:2243–2251. 2008. View Article : Google Scholar : PubMed/NCBI
15	Yap J, Salamonsen LA, Jobling T, Nicholls PK and Dimitriadis E: Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma. Reprod Biol Endocrinol. 8:632010. View Article : Google Scholar : PubMed/NCBI
16	Cuman C, Menkhorst EM, Rombauts LJ, Holden S, Webster D, Bilandzic M, Osianlis T and Dimitriadis E: Preimplantation human blastocysts release factors that differentially alter human endometrial epithelial cell adhesion and gene expression relative to IVF success. Hum Reprod. 28:1161–1171. 2013. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Van Sinderen M, Cuman C, Winship A, Menkhorst E and Dimitriadis E: The chrondroitin sulfate proteoglycan (CSPG4) regulates human trophoblast function. Placenta. 34:907–912. 2013. View Article : Google Scholar : PubMed/NCBI
19	Lay V, Yap J, Sonderegger S and Dimitriadis E: Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. Int J Oncol. 41:759–764. 2012.PubMed/NCBI
20	Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
21	Møller HD, Ralfkjær U, Cremers N, Frankel M, Pedersen RT, Klingelhöfer J, Yanagisawa H, Grigorian M, Guldberg P, Sleeman J, et al: Role of fibulin-5 in metastatic organ colonization. Mol Cancer Res. 9:553–563. 2011. View Article : Google Scholar : PubMed/NCBI
22	Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, et al: Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature. 415:171–175. 2002. View Article : Google Scholar : PubMed/NCBI
23	Meng YG, Han WD, Zhao YL, Huang K, Si YL, Wu ZQ and Mu YM: Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin. Cell Res. 17:869–880. 2007. View Article : Google Scholar : PubMed/NCBI
24	Perlino E, Loverro G, Maiorano E, Giannini T, Cazzolla A, Napoli A, Fiore MG, Ricco R, Marra E and Selvaggi L: Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma. Br J Cancer. 77:1260–1266. 1998. View Article : Google Scholar : PubMed/NCBI
25	Shaul YD and Seger R: The MEK/ERK cascade: From signaling specificity to diverse functions. Biochim Biophys Acta. 1773:1213–1226. 2007. View Article : Google Scholar : PubMed/NCBI